FFCP PHASE1:Mm9::chr3:68310831..68310837,+: Difference between revisions
From FANTOM5_SSTAR
No edit summary |
No edit summary |
||
Line 1: | Line 1: | ||
{{FFCP|EntrezGene=NA|HGNC=|MCL_coexpression_id=252|UniProt=NA|association_with_transcript=NA|description=CAGE_peak_at_chr3:68310831..68310837,+|id=chr3:68310831..68310837,+|ontology_enrichment_celltype=|ontology_enrichment_celltype_v019_2=|ontology_enrichment_disease=|ontology_enrichment_disease_v019_2=|ontology_enrichment_uberon=UBERON:0002113!3.58e-34!14;UBERON:0003918!3.58e-34!14;UBERON:0005095!3.58e-34!14;UBERON:0007687!3.58e-34!14;UBERON:0006554!6.55e-30!16;UBERON:0001008!3.74e-28!17;UBERON:0000489!8.53e-23!21;UBERON:0003103!4.41e-11!43;UBERON:0005172!1.06e-09!49;UBERON:0005173!1.06e-09!49;UBERON:0002417!1.06e-09!49;UBERON:0000916!1.06e-09!49;UBERON:0009569!3.89e-07!66;UBERON:0005177!4.07e-07!85|ontology_enrichment_uberon_v019_2=UBERON:0002113,1.36e-19,14;UBERON:0003918,1.36e-19,14;UBERON:0011143,1.36e-19,14;UBERON:0005095,1.36e-19,14;UBERON:0007687,1.36e-19,14;UBERON:0006554,1.68e-15,18;UBERON:0001008,9.58e-15,19;UBERON:0000489,1.90e-13,21;UBERON:0003103,4.30e-07,43|phase1_expression=0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.610953983535943,0.969762435838129,1.26244475802573,2.27651533647326,0.590440591918409,1.56998727841375,0.370191491765402,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.316036757935816,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.0762068066549998,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0|short_description=p@chr3:68310831..68310837,+}} | {{FFCP | ||
|DHSsupport=NA | |||
|DPIdataset=NA | |||
|EntrezGene=NA | |||
|HGNC= | |||
|MCL_coexpression_id=252 | |||
|TSSclassifier=NA | |||
|UniProt=NA | |||
|association_with_transcript=NA | |||
|cluster_id=chr3:68310831..68310837,+ | |||
|description=CAGE_peak_at_chr3:68310831..68310837,+ | |||
|id=chr3:68310831..68310837,+ | |||
|ontology_enrichment_celltype= | |||
|ontology_enrichment_celltype_v019_2= | |||
|ontology_enrichment_disease= | |||
|ontology_enrichment_disease_v019_2= | |||
|ontology_enrichment_uberon=UBERON:0002113!3.58e-34!14;UBERON:0003918!3.58e-34!14;UBERON:0005095!3.58e-34!14;UBERON:0007687!3.58e-34!14;UBERON:0006554!6.55e-30!16;UBERON:0001008!3.74e-28!17;UBERON:0000489!8.53e-23!21;UBERON:0003103!4.41e-11!43;UBERON:0005172!1.06e-09!49;UBERON:0005173!1.06e-09!49;UBERON:0002417!1.06e-09!49;UBERON:0000916!1.06e-09!49;UBERON:0009569!3.89e-07!66;UBERON:0005177!4.07e-07!85 | |||
|ontology_enrichment_uberon_v019_2=UBERON:0002113,1.36e-19,14;UBERON:0003918,1.36e-19,14;UBERON:0011143,1.36e-19,14;UBERON:0005095,1.36e-19,14;UBERON:0007687,1.36e-19,14;UBERON:0006554,1.68e-15,18;UBERON:0001008,9.58e-15,19;UBERON:0000489,1.90e-13,21;UBERON:0003103,4.30e-07,43 | |||
|phase1_expression=0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.610953983535943,0.969762435838129,1.26244475802573,2.27651533647326,0.590440591918409,1.56998727841375,0.370191491765402,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.316036757935816,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.0762068066549998,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0 | |||
|short_description=p@chr3:68310831..68310837,+ | |||
}} |
Latest revision as of 23:28, 3 August 2015
Short description: | p@chr3:68310831..68310837, + |
---|---|
Species: | Mouse (Mus musculus) |
DPI dataset: | NA |
TSS-like-by-RIKEN-classifier(Yes/No): | NA |
DHS support(Yes/No): | NA |
Description: | CAGE_peak_at_chr3:68310831..68310837, + |
Coexpression cluster: | MCL_coexpression_mm9:252 |
Association with transcript: | NA |
EntrezGene: | NA |
Link to Zenbu: | ZENBU |
View on UCSC genome browser
CAGE Expression
- Click each plot point to find sample in table
Ontology-based sample term enrichment analysis<b>Summary:</b>This analysis has been performed by utilizing wilcoxon rank sum test.When the number of associated cells/tissues are > n , randomly sampled n cells/tissues are used for P value calculation with rank sum test. this process are repeated several times, and the P values are averaged on the log space <br><b>Analyst:</b> Hideya Kawaji<br><br>link to source dataset<br>data
Ontology term | p-value | n |
---|---|---|
kidney | 1.36e-19 | 14 |
kidney mesenchyme | 1.36e-19 | 14 |
upper urinary tract | 1.36e-19 | 14 |
kidney rudiment | 1.36e-19 | 14 |
kidney field | 1.36e-19 | 14 |
urinary system structure | 1.68e-15 | 18 |
renal system | 9.58e-15 | 19 |
cavitated compound organ | 1.90e-13 | 21 |
compound organ | 4.30e-07 | 43 |